Table 3.
Change in population for “All Types” of Ae. aegypti occurrence patterns for 2061-2080 versus 1950-2000, for each region, SSP pathway, and RCP scenario, as well as the difference of the RCP8.5 and RCP4.5 scenarios.*
| Reference | RCP4.5 | RCP8.5 | RCP8.5-minus-RCP4.5 | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 1950-2000 | Δ 2061-2080 | Δ 2061-2080 | Δ 2061-2080 | |||||||
| Region | GPW | GPW | SSP3 | SSP5 | GPW | SSP3 | SSP5 | GPW | SSP3 | SSP5 |
| Africa | 664 | 16 | 2093 | 1023 | 19 | 2104 | 1029 | 3 | 10 | 6 |
| Asia | 2538 | 145 | 2172 | 747 | 202 | 2334 | 846 | 58 | 162 | 99 |
| Australia | 17 | 4 | 17 | 43 | 5 | 18 | 45 | 1 | 1 | 2 |
| Europe | 44 | 64 | 48 | 113 | 129 | 106 | 194 | 65 | 58 | 81 |
| N. America | 253 | 56 | 245 | 236 | 84 | 280 | 290 | 28 | 35 | 54 |
| S. America | 277 | 13 | 230 | 70 | 20 | 243 | 78 | 7 | 13 | 9 |
| Global | 3794 | 298 | 4805 | 2232 | 460 | 5084 | 2483 | 162 | 279 | 251 |
*
underlined italicized values indicate statistically significant (p<0.05) changes for 2061-2080 compared to 1950-2000 for the RCP4.5 and RCP8.5 scenarios. For the RCP8.5-minus-RCP4.5 scenario, italicized underlined values indicate statistically significant differences (p<0.05) for the RCP8.5 versus RCP4.5 scenario